NASDAW:EDGE Shareholder Notice: Lawsuit Alleges Misleading Statements by Edge Therapeutics, Inc
An investor, who purchased NASDAW:EDGE shares, filed a lawsuit over alleged violations of Federal Securities Laws by Edge Therapeutics, Inc.
View full press release